Previous 10 | Next 10 |
Microbot Medical (NASDAQ:MBOT) has promoted Rachel Vaknin as its Chief Financial Officer (CFO), effective Apr. 1, 2022. Ms. Vaknin is a seasoned finance executive with 20 years of experience. She joined Microbot in Jan'22 as VP Finance and succeeds David Ben Naim as CFO. Ben Naim had served a...
HINGHAM, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), seeking to continuously enhance its core capabilities, today announced the promotion of Rachel Vaknin as its Chief Financial Officer. Ms. Vaknin, a seasoned finance executive with 20 years of expe...
HINGHAM, Mass., March 31, 2022 (GLOBE NEWSWIRE) -- The operational momentum that Microbot Medical Inc. (Nasdaq: MBOT) experienced at the end of 2021 has continued well into the 2022 first quarter. The Company filed its pre-submission package for the LIBERTY ® Robotic System with th...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips “Blood bath” would be an appropriate term to use for today’s price action in the markets. This goes double for highly speculative growth stocks . However, investors looking for silver linings among tod...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The winds in the stock market are starting to pick up. Investors looking for growth are getting slammed by concerns about rising interest rates. Today, bond yields surged to their highest levels since the onset of the Covid...
3 Health Care Stocks To Check Out For The New Year Even with the stock market seemingly riding a potential Santa rally this week, the pandemic continues to rage on. As a result, investors may want to consider keeping an eye on health care stocks now. To highlight, the Omicro...
Gainers: Altamira Therapeutics (NASDAQ:CYTO) +21%, Regencell Bioscience (NASDAQ:RGC) +17%, BridgeBio Pharma BBIO +13%, ImmunityBio (NASDAQ:IBRX) +8%, BiondVax Pharmaceuticals BVXV +8%. Losers: Biofrontera (NASDAQ:BFRI) -21%, Microbot Medical (...
Gainers: PyroGenesis Canada (NASDAQ:PYR) +72%. Microbot Medical MBOT +50%. CollPlant Biotechnologies CLGN +32%. Future FinTech FTFT +41%. American Virtual Cloud Technologies (NASDAQ:AVCT) +23%. Spruce Biosciences (NASDAQ:SPRB) +31%. Tarena International TEDU +19%. CNF...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Microbot Medical (NASDAQ: MBOT ) is soaring 51% after an agreement with Stryker (NYSE: SYK ) was announced. The companies plan to collaborate to develop the first robotic procedural kits for certain neurov...
Gainers: Microbot Medical (NASDAQ:MBOT) +51%, CollPlant Biotechnologies (NASDAQ:CLGN) +27%, Lucira Health (NASDAQ:LHDX) +14%, IceCure Medical (NASDAQ:ICCM) +13%, Cue Health (NASDAQ:HLTH) +12%. Losers: BridgeBio Pharma (NASDAQ:BBIO) -71%, Biond...
News, Short Squeeze, Breakout and More Instantly...
Microbot Medical Inc. Company Name:
MBOT Stock Symbol:
NASDAQ Market:
Microbot Medical Inc. Website:
BRAINTREE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announces it has received Institutional Review Board (IRB) approval and signed a clinical trial agreement with Memor...
Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical Trial. The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular R...
The first clinical case was performed at Brigham and Women’s Hospital The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular Robotic Surgical System BRAINTREE, Mass., July 08, 2024 (G...